Acute Lymphoblastic Leukemia

Filter By:
05:19
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Denis-Claude Roy (University of Montreal, Montreal, Canada) discusses a phase II trial that evaluated selective photodepletion of recipient-allor​eactive T-cells (ATIR) for haploidentical haematopoietic stem cell transplant in patien...
by:EMJ | 104 views
09:31
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Catherine Bollard from Children's National Health System joined Patient Power to share encouraging news for the treatment of the relapsed/refrac​tory lymphoma and acute lymphoblastic leukemia (ALL). Dr. Bollard discusses how exp...
by:patientpower | 129 views
24:10
In this “Best of the Day” presentation from the 2014 Annual Hematology Meeting in San Francisco, Dr. Joseph R. Mikhael and Dr. David P. Steensma review and discuss pertinent clinical trials and late breaking updates on therapeutic options and management strategies for patients with myelodysplastic syndromes (MDS), acute lymphocytic leukemia (ALL) a...
by:imedex | 107 views
23:32
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Catherine Bollard (Children's National Medical Center, Washington, DC), Dr Philippe Armand (Dana-Farber Cancer Institute, Boston, MA), Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY), Dr Nicola Gökbuget (Un...
by:EMJ | 156 views
06:39
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Stephan Grupp (Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA) presents the results of a study that suggests chimeric antigen receptor (CAR) T cells targeting CD19 (CTL...
by:EMJ | 200 views
13:22
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr David Steensma (Dana-Farber Cancer Institute, Boston, MA), Dr Brent Wood (University of Washington, Seattle, WA), Prof Wendy Stock (University of Chicago Medical Center, Chicago, IL), Dr Christoph Röllig (Universitätskli​nikum Dresde...
by:EMJ | 169 views
06:40
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-Universi​ty Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evaluated nilotinib and chemotherapy for first-line treatme...
by:EMJ | 111 views
06:39
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Wendy Stock (University of Chicago Medical Center, Chicago, IL) discusses the intergroup trial C10403, which showed that adolescent and young adult patients (16–39 years old) with acute lymphoblastic leuk...
by:EMJ | 96 views
05:35
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Brent Wood (University of Washington, Seattle, WA) discusses the phase III Children's Oncology Group (COG) study AALL0434, which evaluated a standard 4-drug induction followed by response-based risk stratif...
by:EMJ | 107 views
09:36
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Nicola Gökbuget (University Hospital Frankfurt, Frankfurt, Germany) presents the results of the single-arm phase II study that evaluated the Bispecific T-Cell Engager (BiTE) antibody construct (anti-CD19) b...
by:EMJ | 218 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)